Badal Shah is a healthcare innovator who founded Neolytica after successfully launching 145+ drugs, including breakthrough COVID treatments. Their AI solutions now empower 25,000+ pharma leaders globally.

Recognized among "Top 100 US Companies" and IFAH's "Top 100 Healthcare Leaders," they pioneer generative AI for clinical trials and opioid risk solutions.

His vision harnesses NLP and data analytics to transform medical communication, rare disease research, and real-world evidence applications.